-
公开(公告)号：US08263586B2
公开(公告)日：2012-09-11
申请号：US12599925
申请日：2008-05-14
IPC分类号： A61K31/00 , A61K31/553 , C07D491/02
CPC分类号： C07D498/08
摘要： The present invention is directed to oxo bridged diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
摘要翻译： 本发明涉及作为食欲素受体的拮抗剂的氧代桥连的二氮杂环庚烷化合物，其可用于治疗或预防涉及食欲素受体的神经和精神病症和疾病。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及食欲肽受体的疾病中的用途。
-
公开(公告)号：US20120136012A1
公开(公告)日：2012-05-31
申请号：US13389270
申请日：2010-08-05
IPC分类号： A61K31/519 , C07D519/00 , A61P25/18 , A61P25/28 , A61P25/14 , C07D471/04 , A61P25/22
CPC分类号： C07D471/04 , C07D519/00
摘要： The present invention is directed to amino tetrahydro-pyridopyrimidine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
摘要翻译： 本发明涉及可用作治疗与磷酸二酯酶10（PDE10）相关的中枢神经系统疾病的治疗剂的氨基四氢 - 吡啶并嘧啶化合物。 本发明还涉及这些化合物用于治疗神经和精神疾病如精神分裂症，精神病或亨廷顿病以及与纹状体功能减退或基底神经节功能障碍相关的疾病的用途。
-
公开(公告)号：US20120046289A1
公开(公告)日：2012-02-23
申请号：US13126654
申请日：2009-10-26
IPC分类号： A61K31/5377 , A61K31/501 , A61P25/20 , C07D403/04 , A61P3/04 , C07D413/14 , C07D401/04 , C07D413/04
CPC分类号： A61K31/405 , A61K31/4439 , C07D333/66
摘要： The present invention is directed to pyridazine carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
摘要翻译： 本发明涉及作为食欲肽受体的拮抗剂的哒嗪甲酰胺化合物，其可用于治疗或预防涉及食欲素受体的神经和精神病症和疾病。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及食欲肽受体的疾病中的用途。
-
公开(公告)号：US20110319409A1
公开(公告)日：2011-12-29
申请号：US12821311
申请日：2010-06-23
IPC分类号： A61K31/5377 , A61P25/18 , A61P25/28 , A61P25/00 , A61K31/519 , C07D471/04
CPC分类号： C07D471/04
摘要： The present invention is directed to 7-aza-quinazoline compounds of general structural formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10).
摘要翻译： 本发明涉及通用结构式I的7-氮杂 - 喹唑啉化合物，其可用作治疗与磷酸二酯酶10（PDE10）相关的中枢神经系统疾病的治疗剂。
-
公开(公告)号：US20100227848A1
公开(公告)日：2010-09-09
申请号：US12599925
申请日：2008-05-14
IPC分类号： A61K31/553 , C07D498/08 , A61K31/551 , A61P25/00 , A61P3/04 , A61P3/00
CPC分类号： C07D498/08
摘要： The present invention is directed to oxo bridged diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
摘要翻译： 本发明涉及作为食欲素受体的拮抗剂的氧代桥连的二氮杂环庚烷化合物，其可用于治疗或预防涉及食欲素受体的神经和精神病症和疾病。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及食欲肽受体的疾病中的用途。
-
公开(公告)号：US20100168134A1
公开(公告)日：2010-07-01
申请号：US12600388
申请日：2008-05-22
IPC分类号： A61K31/4545 , C07D417/14 , C07D401/14 , C07D413/14 , C07D401/12 , A61K31/506 , A61P25/00 , A61P3/04
CPC分类号： C07D401/12 , C07D401/14 , C07D413/14 , C07D417/14
摘要： The present invention is. directed to pyridyl piperidine compounds of formula (I) which are antagonists of orexin receptors, and which are useful' in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
摘要翻译： 本发明是。 涉及作为食欲素受体的拮抗剂的式（I）的吡啶基哌啶化合物，其可用于治疗或预防涉及食欲肽受体的神经和精神病症和疾病。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及食欲肽受体的疾病中的用途。
-
公开(公告)号：US07723365B2
公开(公告)日：2010-05-25
申请号：US11660288
申请日：2005-08-15
IPC分类号： A61K31/4245 , C07D271/10
CPC分类号： C07D271/107
摘要： The present invention relates to oxadiazoles that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also relates to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译： 本发明涉及可用于治疗细胞增殖性疾病，用于治疗与KSP驱动蛋白活性相关的疾病和用于抑制KSP驱动蛋白的恶二唑。 本发明还涉及包含这些化合物的组合物，以及使用它们治疗哺乳动物癌症的方法。
-
公开(公告)号：US20100029736A1
公开(公告)日：2010-02-04
申请号：US12302122
申请日：2007-07-13
IPC分类号： A61K31/4184 , C07D403/06 , C07D403/12 , A61P3/04
CPC分类号： C07D403/06 , C07D403/12 , C07D403/14
摘要： The present invention is directed to 2-substituted proline bis-amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
摘要翻译： 本发明涉及作为食欲素受体的拮抗剂的2-取代的脯氨酸双酰胺化合物，其可用于治疗或预防涉及食欲素受体的神经和精神病症和疾病。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及食欲肽受体的疾病中的用途。
-
公开(公告)号：US07638549B2
公开(公告)日：2009-12-29
申请号：US10568000
申请日：2004-08-11
IPC分类号： A61K31/4025 , C07D207/09 , C07D207/20
CPC分类号： C07D403/12
摘要： The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译： 本发明涉及可用于治疗细胞增殖性疾病，用于治疗与KSP驱动蛋白活性相关的病症和用于抑制KSP驱动蛋白的二氢吡咯化合物。 本发明还涉及包含这些化合物的组合物，以及使用它们治疗哺乳动物癌症的方法。
-
公开(公告)号：US20090042966A1
公开(公告)日：2009-02-12
申请号：US11887800
申请日：2006-04-03
IPC分类号： A61K31/415 , C07D231/06 , A61P35/00
CPC分类号： C07D231/06
摘要： The present invention relates to fluorinated dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译： 本发明涉及可用于治疗细胞增殖性疾病，用于治疗与KSP驱动蛋白活性相关的疾病和用于抑制KSP驱动蛋白的氟化二氢吡唑化合物。 本发明还涉及包含这些化合物的组合物，以及使用它们治疗哺乳动物癌症的方法。
-
-
-
-
-
-
-
-
-
搜索结果
72 条记录 (耗时 0.045 秒)
